Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Altasciences Selects Proscia To Accelerate The Development Of Life-Saving Drugs

By Author Proscia | March 22, 2023

Altasciences will initially deploy Concentriq for Research to unify massive volumes of study data and streamline collaboration among internal and external stakeholders, enabling its scientists to draw faster, more complete conclusions and increasingly work as an extension of sponsors’ teams. The CRO also plans to draw on the platform’s newly expanded capabilities for GLP compliant studies as well as leverage its world-class interoperability to unlock new insights with AI.

Our website uses cookies. By using this site, you agree to its use of cookies.